These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6136093)

  • 1. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.
    White FJ; Wang RY
    Science; 1983 Sep; 221(4615):1054-7. PubMed ID: 6136093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
    Rasmussen K; Hsu MA; Yang Y
    Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR; White FJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.
    Stockton ME; Rasmussen K
    Neuropsychopharmacology; 1996 Feb; 14(2):97-105. PubMed ID: 8822532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1986 Sep; 25(9):995-1001. PubMed ID: 2877417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1983 Aug; 3(8):1607-19. PubMed ID: 6135762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of E-5842, a sigma1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons.
    Sánchez-Arroyos R; Guitart X
    Eur J Pharmacol; 1999 Jul; 378(1):31-7. PubMed ID: 10478562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective dopamine D4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats.
    Kawashima N; Okuyama S; Omura T; Chaki S; Tomisawa K
    Life Sci; 1999; 65(24):2561-71. PubMed ID: 10619364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the rat.
    Piontek JA; Wang RY
    Life Sci; 1986 Aug; 39(7):651-8. PubMed ID: 2874468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells.
    Grenhoff J; Ugedo L; Svensson TH
    Acta Physiol Scand; 1988 Sep; 134(1):127-32. PubMed ID: 3239415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroquel: electrophysiological profile of a potential atypical antipsychotic.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Psychopharmacology (Berl); 1993; 112(2-3):293-8. PubMed ID: 7871033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute thioridazine, metoclopramide and SCH 23390 on the basal activity of A9 and A10 dopamine cells.
    Hand TH; Kasser RJ; Wang RY
    Eur J Pharmacol; 1987 Jun; 137(2-3):251-5. PubMed ID: 2886354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
    Moore AE; Cicchetti F; Hennen J; Isacson O
    Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
    Hand TH; Hu XT; Wang RY
    Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs.
    Todorova A; Dimpfel W
    Eur Neuropsychopharmacol; 1994 Dec; 4(4):491-501. PubMed ID: 7894260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats.
    Kawashima N; Funakoshi T; Omura T; Chaki S; Kameo K; Okuyama S
    Eur J Pharmacol; 2001 Jun; 423(1):27-33. PubMed ID: 11438303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y; Emori K; Ashby CR
    Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.